Pericardiocentesis: History, Current Practice, and Future Directions.

Percutaneous balloon pericardiotomy Pericardial disease Pericardiocentesis

Journal

Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969

Informations de publication

Date de publication:
14 Sep 2024
Historique:
accepted: 05 09 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 14 9 2024
Statut: aheadofprint

Résumé

To discuss the evolution in the approach to pericardial effusions and drainage from a historical perspective, the present state, and pathways for future innovative therapies. Incorporation of advanced imaging tools has dramatically improved the safety profile of pericardial interventions. Outcome data allow for refined approaches to management of pericardial disease in special populations, such as pulmonary arterial hypertension. Consideration of intrapericardial interventions and pharmacotherapy represent novel and promising approaches to management of pericardial effusions moving forward. Although the impact of excess or rapidly accumulating pericardial fluid on hemodynamics has been recognized for centuries, the therapeutic approaches have only recently become more refined with the routine incorporation of such tools as echocardiography and fluoroscopy. The most utilized approaches for pericardiocentesis include the apical, subxiphoid, and parasternal, and the most favorable approach is that in which the pericardial fluid is closest to the body surface, where intervening vital structures are least likely to be damaged. With the notable exception of patients with pre-existing pulmonary hypertension, complete decompression of pericardial fluid with careful drain management reduces likelihood of pericardial effusion recurrence. In addition, percutaneous balloon pericardiotomies have been demonstrated to reduce recurrence in nonmalignant effusions.

Identifiants

pubmed: 39276266
doi: 10.1007/s11886-024-02134-2
pii: 10.1007/s11886-024-02134-2
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Fowler RC. On the heart of the Hippocratic Corpus: its meaning, context and purpose. Med Hist. 2023;67(3):266–83.
doi: 10.1017/mdh.2023.22 pubmed: 37668381 pmcid: 10482573
Winslow N, Shipley AM. Pericardiotomy for pyopericardium: review of literature to may, 1927, and report of ten new cases. Arch Surg. 1927;15(3):317–50.
Abdel-Halim RE. Contributions of Ibn Zuhr (Avenzoar) to the progress of surgery: a study and translations from his book Al-Taisir. Saudi Med J. 2005;26(9):1333–9.
pubmed: 16155644
Tubbs RS, Loukas M, Shoja MM, Ardalan MR, Oakes WJ. Richard Lower (1631–1691) and his early contributions to cardiology. Int J Cardiol. 2008;128(1):17–21.
doi: 10.1016/j.ijcard.2007.11.069 pubmed: 18201782
Bosher C, Westaby S. Landmarks in cardiac surgery. Taylor & Francis; 1998.
Riolan J. Opuscula nova anatomica. M. Dupuis; 1653.
Maisch B, Ristic AD, Seferovic PM, Tsang TSM. Interventional pericardiology: Pericardiocentesis, Pericardioscopy, Pericardial Biopsy, Balloon Pericardiotomy, and Intrapericardial Therapy. Springer Berlin Heidelberg; 2011.
Kilpatrick ZM, Chapman CB. On pericardiocentesis. Am J Cardiol. 1965;16(5):722–8.
doi: 10.1016/0002-9149(65)90057-3 pubmed: 5319921
Tóth I, Rami-Porta R, Rendeki S, Molnár TF. First steps in the management of Pericardial Effusion: who was First to relieve the Pericardial Sac—Larrey or Romero? World J Surg. 2013;37(9):2242–5.
doi: 10.1007/s00268-013-2115-5 pubmed: 23722467
Wayand W, Feil W, Skopec M. Surgery in Austria. Arch Surg. 2002;137(2):217–20.
doi: 10.1001/archsurg.137.2.217 pubmed: 11822963
Kil UH, Jung HO, Koh YS, Park HJ, Park CS, Kim PJ, et al. Prognosis of large, symptomatic pericardial effusion treated by echo-guided percutaneous pericardiocentesis. Clin Cardiol. 2008;31(11):531–7.
doi: 10.1002/clc.20305 pubmed: 19006110 pmcid: 6653504
Adler Y, Charron P, Imazio M, Badano L, Baron-Esquivias G, Bogaert J, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of Pericardial diseases of the European Society of Cardiology (ESC)endorsed by: the European Association for Cardio-thoracic surgery (EACTS). Eur Heart J. 2015;36(42):2921–64.
doi: 10.1093/eurheartj/ehv318 pubmed: 26320112
Rafique AM, Patel N, Biner S, Eshaghian S, Mendoza F, Cercek B, et al. Frequency of recurrence of pericardial tamponade in patients with extended versus nonextended pericardial catheter drainage. Am J Cardiol. 2011;108(12):1820–5.
doi: 10.1016/j.amjcard.2011.07.057 pubmed: 21907951
Tsang TS, Enriquez-Sarano M, Freeman WK, Barnes ME, Sinak LJ, Gersh BJ, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002;77(5):429–36.
doi: 10.1016/S0025-6196(11)62211-8 pubmed: 12004992
Horr SE, Mentias A, Houghtaling PL, Toth AJ, Blackstone EH, Johnston DR, et al. Comparison of outcomes of pericardiocentesis versus surgical pericardial window in patients requiring drainage of pericardial effusions. Am J Cardiol. 2017;120(5):883–90.
doi: 10.1016/j.amjcard.2017.06.003 pubmed: 28739031
Sagrista-Sauleda J, Angel J, Sanchez A, Permanyer-Miralda G, Soler-Soler J. Effusive-constrictive pericarditis. N Engl J Med. 2004;350(5):469–75.
doi: 10.1056/NEJMoa035630 pubmed: 14749455
Vasquez MA, Iskander M, Mustafa M, Quintero-Martinez JA, Luna A, Mintz J, et al. Pericardiocentesis outcomes in patients with pulmonary hypertension: a nationwide analysis from the United States. Am J Cardiol. 2024;210:232–40.
doi: 10.1016/j.amjcard.2023.10.047 pubmed: 37875232
Fenstad ER, Le RJ, Sinak LJ, Maradit-Kremers H, Ammash NM, Ayalew AM, et al. Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage. Chest. 2013;144(5):1530–8.
doi: 10.1378/chest.12-3033 pubmed: 23949692
Akyuz S, Zengin A, Arugaslan E, Yazici S, Onuk T, Ceylan US, et al. Echo-guided pericardiocentesis in patients with clinically significant pericardial effusion. Outcomes over a 10-year period. Herz. 2015;40(Suppl 2):153–9.
doi: 10.1007/s00059-014-4187-x pubmed: 25491665
Maggiolini S, Gentile G, Farina A, De Carlini CC, Lenatti L, Meles E, et al. Safety, efficacy, and complications of pericardiocentesis by real-time echo-monitored procedure. Am J Cardiol. 2016;117(8):1369–74.
doi: 10.1016/j.amjcard.2016.01.043 pubmed: 26956635
Sobieski C, Herner M, Goyal N, Khor LL, Chang L, Bieging E, et al. Pericardial Decompression Syndrome after Drainage of Chronic Pericardial effusions. JACC Case Rep. 2022;4(22):1515–21.
doi: 10.1016/j.jaccas.2022.08.023 pubmed: 36444176 pmcid: 9700074
Ziskind AA, Pearce AC, Lemmon CC, Burstein S, Gimple LW, Herrmann HC, et al. Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and large pericardial effusions: description of technique and report of the first 50 cases. J Am Coll Cardiol. 1993;21(1):1–5.
doi: 10.1016/0735-1097(93)90710-I pubmed: 8417048
Marcano J, Campos K, Rodriguez V, Handy K, Brewer MA, Cohn WE. Intrapericardial delivery of amiodarone rapidly achieves therapeutic levels in the atrium. Heart Surg Forum. 2013;16(5):E279-86.
doi: 10.1532/HSF98.2013188 pubmed: 24364084
Roques C, Salmon A, Fiszman MY, Fattal E, Fromes Y. Intrapericardial administration of novel DNA formulations based on thermosensitive Poloxamer 407 gel. Int J Pharm. 2007;331(2):220–3.
doi: 10.1016/j.ijpharm.2006.11.056 pubmed: 17187948
Fei L, Baron AD, Henry DP, Zipes DP. Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properties. Circulation. 1997;96(11):4044–9.
doi: 10.1161/01.CIR.96.11.4044 pubmed: 9403630
Hou D, Rogers PI, Toleikis PM, Hunter W, March KL. Intrapericardial paclitaxel delivery inhibits neointimal proliferation and promotes arterial enlargement after porcine coronary overstretch. Circulation. 2000;102(13):1575–81.
doi: 10.1161/01.CIR.102.13.1575 pubmed: 11004150

Auteurs

Aravind Kalluri (A)

Division of Cardiology, Department of Medicine, Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Weili Zheng (W)

Division of Cardiology, Department of Medicine, Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Kelley Chen (K)

Division of Cardiology, Department of Medicine, Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Jason Katz (J)

Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Mohamed Al-Kazaz (M)

Division of Cardiology, Department of Medicine, Northwestern Memorial Hospital Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Paul C Cremer (PC)

Division of Cardiology, Departments of Medicine and Radiology, Northwestern Memorial Hospital Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Daniel R Schimmel (DR)

Feinberg School of Medicine, Northwestern Memorial Hospital, 675 N St Clair St Ste 19-100 Galter Pavilion, Chicago, IL, 60611-5969, USA. dschimme@nm.org.

Classifications MeSH